Healing Starts with a Frequency

EMulate Therapeutics uses ultra-low radio frequency energy to influence cell behavior and support targeted therapeutic outcomes.

Explore the Technology
A new class of digital therapeutics.

A Wearable Therapeutic for Real-World Care

EMulate's proprietary ulRFE® technology provides non-ionizing, non-invasive, non-thermal therapy designed to emulate the activity of validated molecules—without delivering the molecules themselves.

Indications We're Targeting

Oncology

Advancing therapies for some of the most difficult-to-treat brain cancers.

Targets:

  • Diffuse Midline Glioma (including DIPG)
  • Glioblastoma Multiforme

Regulatory Status:

  • FDA Humanitarian Device Exemption submitted (Q2 2024)
  • Phase 3 ready

Mental Health

Developing signal-based interventions for neuropsychiatric conditions.

Targets:

  • PTSD
  • Depression
  • Anxiety
  • Addiction

Regulatory Status:

  • Phase 1 ready

Pain Relief

Non-opioid, non-pharmacologic pain modulation for humans and animals.

Targets:

  • Acute and chronic pain
  • Animal health

Regulatory Status:

  • Phase 1 ready
How It Works

The Science of Bioelectromagnetics.

EMulate Therapeutics uses ultra-low radio frequency energy to influence cell behavior and support targeted therapeutic outcomes.

Encode Molecular Signatures

We identify and capture the electromagnetic behavior of therapeutic molecules.

Deliver Ultra-Low EM Fields

These encoded signatures are transmitted into the body through a wearable device.

Cellular Interpretation

Cells interpret the signals as if the molecules themselves were present.

Biological Pathways Respond

Targeted pathways become active, supporting restoration, balance, and recovery.

Ways to invest

Be Part of the Breakthrough

Participate through Wefunder, our current platform for engaging new investors.

Wefunder

Our equity crowdfunding round on Wefunder is open to both accredited and non-accredited investors. This campaign supports our clinical progress, technology expansion, and near-term commercialization efforts.

Invest on WeFunder

Latest News

The EMulate Family

Cellsana

Oncology-focused applications powered by EM signature technology.

Mensana

Neurological and mental-health therapeutics targeting brain function and cognitive balance.

Indolor

Drug-free pain management solutions using targeted EM field modulation.